☰
✕

Neurofeedback systems market

Neurofeedback Market, by Product (Amplifiers, Electrodes or Sensors, and Computer Software), by System (Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Request Free Sample
  • Mar 2023
  • CMI5506
  • 182 Pages
  • Excel & Pdf
  • Medical Devices

Global neurofeedback market is estimated to be valued at US$ 1,253.5 million in 2023 and is expected to exhibit a CAGR of 7.33% during the forecast period (2023-2030).

Increase in inorganic growth strategies such as acquisitions by the key players in the market is expected to drive the market growth over the forecast period. Moreover, an increase in the initiatives of government and non-government organizations to increase the awareness among people regarding mental disease is expected to drive the market growth.

Analysts’ Views on Global Neurofeedback Market:

Increase in inorganic strategies such as acquisition by the key players in the market is expected to drive the growth of the global neurofeedback market over the forecast period. For instance, on November 2021, LiveToBeHappy, Inc., a land developer and community home builder announced its acquisition of RenuYou, which is a Board Certified (BCIA) clinic, referred to patients by the Mayo Clinic, for the treatment, research, and development of neurofeedback. This acquisition helped LiveToBeHappy, Inc., its effort to promote an integrated lifestyle for housing, education, and wellness.

Figure 1. Global Neurofeedback Market Share (%), By System, 2023

Global Neurofeedback Market – Driver

Increasing Prevalence of Mental Disorders

Increasing prevalence of mental disorders such as anxiety, schizophrenia, depression, and others is expected to drive growth of the global neurofeedback market over the forecast period. For instance, data published in April 2021, on National Library of Medicine, stated that schizophrenia affects more than 1.5 million Canadians every year.

Neurofeedback Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 1,253.5 Mn
Historical Data for: 2017 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 7.33% 2030 Value Projection: US$ 2,056.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product: Amplifiers, Electrodes or Sensors, Computer Software
  • By System: Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), Functional Magnetic Resonance Imaging (fMRI)
  • By Application: Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, Others 
  • By End User: Hospitals, Ambulatory Surgical Center, Clinics, Others
Companies covered:

Neuro Care Group, Myndlift Ltd, Brainmaster Technologies, Inc., Mitsar Co. Ltd, Emotiv, Brainworks, Mindfield Biosystems Ltd. , Narbis, Thought Technology Ltd., InteraXon Inc., Mind Media USA Inc., and NeuralScan
Growth Drivers:
  • Increasing prevalence of mental disorders
  • Increasing inorganic growth strategies such as collaboration
Restraints & Challenges:
  • The side effects associated with the neurofeedback therapy

Increasing inorganic growth strategies such as collaborations

Increasing inorganic growth strategies such as collaborations by key players is expected to drive the market growth over the forecast period. For instance, in November 2021, OVID Clinics GmbH, a company providing clinical psychotherapy services to patients and developing psychedelic molecules and Divergence NeuroTechnologies, a company focused on the research and development of a data-driven, cloud-based neuro platform leveraging EEG-analysis and machine learning. This acquisition was done to improve assessment technology and enhance the relationship between healthcare providers and individuals, collaborated to develop a cloud-based clinical assessment and neurofeedback software solution.

Figure 2. Global Neurofeedback Market Share (%), By Region, 2022

Global Neurofeedback Market - Regional Analysis

Among regions, North America is expected to dominate the market over the forecast period. This is attributed due to the increasing prevalence of sleep disorders such as insomnia, sleep apnea, and others. For instance, as per the data published on January 20, 2022, on SingleCare Administrators, an authorized prescription discount plan organization, stated that in the U.S., around 25 million adults were affected by sleep apnea in 2021.

Europe is expected to be second dominating region over the forecast period, due to an increase in the awareness of mental disorders by the government. For instance, on September 21, 2022, National Health Service (NHS) launched mental health campaign for young people in London, U.K. In an effort to encourage young people to come forward for support early and potentially prevent experiencing a mental health emergency.

Global Neurofeedback Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to World Health Organization (WHO) as of October 10, 2022, 44,614,437 people were affected worldwide.

People's mental health was significantly impacted by the COVID-19 pandemic, which caused many people to acquire a variety of psychiatric and neuropsychiatric conditions. Anxiety disorders affected 75.2 million people in 2020, according to a study titled ‘Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories due to the COVID-19 Pandemic.

Global Neurofeedback Market Segmentation:

The global neurofeedback market report is segmented into product, system, application, end user and region

Based on Product, the market is segmented into amplifiers, electrodes or sensors, and computer software. Out of which, amplifiers segment is expected to dominate the neurofeedback market during the forecast period and this is attributed to increase in the usage of amplifiers in the neurofeedback systems/devices. For instance, on October 22, 2020, Narbis, a medical device company launched a new pair of smart glasses uses a technique invented at National Aeronautics and Space Administration (NASA) to measure users’ brainwaves.

Based on System, the market is segmented into Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA) and Functional Magnetic Resonance Imaging (fMRI). Out of which, Frequency/Power Neurofeedback System segment is expected to dominate the market over the forecast period and this is attributed to increase in the number of research and development for treatment of various diseases such as anxiety, headache, and others using frequency/power neurofeedback system. For instance, on May 20, 2022, Infra-Low Frequency Neurofeedback in Tension-Type Headache: A Cross-Over Sham-Controlled Study was conducted by M. V. Lomonosov Moscow State University, Moscow, Russia.

Based on Application, the market is segmented into attention deficit hyperactivity disorder (ADHD), anxiety, depression, epilepsy, insomnia, drug addiction, schizophrenia, and others. Attention deficit hyperactivity disorder (ADHD) segment is expected to dominate the market over the forecast period and this is attributed to increase in the clinical trials of using neurofeedback for treatment of attention deficit hyperactivity disorder (ADHD). For instance, on May 7, 2020, Fondation Lenval, a children welfare organization, initiated a study titled “Comparison of 2 Neurofeedback Protocols in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents”. This study is estimated to be concluded by December 2023.

Based on End User, the neurofeedback market is segmented into hospitals, ambulatory surgical center, clinics, and others. Hospitals segment is expected to dominate the market over the forecast period and this is attributed to the increase in the prevalence of mental disorders such as anxiety, depression, schizophrenia and others as this will increase hospitalization of patients. For instance, as per data published on January 12, 2022, on treatment advocacy center, a non-profit organization, stated that in the U.S schizophrenia affected around 2.8 million people in 2021.

Among all segmentation, application segment has highest potential due to increase in the number of traumatic brain injuries. For instance, according to an article published in March 2022, on Centers for Disease Control and Prevention (CDC), stated that in the U.S. there were around 64,362 Traumatic Brain Injury (TBI) related deaths in 2020.

Global Neurofeedback Market Cross Sectional Analysis

Among application, anxiety is a dominant segment in Asia Pacific region due to increasing prevalence of anxiety disorder in the region. For instance, according to data published on December 12, 2022, on Australian Institute of Health and Welfare, stated that in Australia there were around 4.2 million people who suffered from anxiety in 2022.

Among end user, clinics segment is a dominant segment in Asia Pacific region due to increasing number of the clinics in the region. For instance, data published on November 2020, on Institut Montaigne, a non-profit organization, stated that in India there were about 43,486 private hospitals in 2020.

Global Neurofeedback Market: Key Developments

In November 2021, OVID Clinics GmbH, a healthcare company and Divergence NeuroTechnologies, a neurotechechnology company, collaborated to develop a cloud-based clinical assessment and neurofeedback software solution.

In October 2021, second iteration of Interaxon Inc., an neurotechnology company’s EEG meditation and sleep headband Muse S was released. Real-time neurofeedback is used by this upgraded plush brain-sensing headband to teach users how to meditate in order to fall asleep.

On November 4, 2022, Neurosteer, a medical device company announced the U.S. Food and Drug Administration (FDA) approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The sensor accepts the signal from the electrode strip and transmits it to the brain activity monitor, which displays the status information alongside the most recently acquired signal.

On November 14, 2022, EMOTIV, a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG), and X-trodes, a company bringing wireless medical-grade monitoring solutions to the home environment, announced collaboration on a new solution for simultaneous brain and physiological measurement that can be used outside of the lab setting.

Global Neurofeedback Market: Restraint

Side effects associated with neurofeedback

The major factors that may hamper growth of the global neurofeedback market over the forecast period include side effects associated with the neurofeedback therapy. Neurofeedback is a type of biofeedback therapy that is used to help treat all kinds of mental health conditions. For instance, data published in March 2021, on website of True Life Center, which is a psychiatric and substance abuse treatment center, stated that side effects of neurofeedback therapy includes social anxiety, low energy or fatigue, internal vibrations, muscle tension, cognitive impairment, and others.

Global Neurofeedback Market: Key Players

Major players operating in the global neurofeedback market include Neuro Care Group, Myndlift Ltd, Brainmaster Technologies, Inc., Mitsar Co. Ltd, Emotiv, Brainworks, Mindfield Biosystems Ltd., Narbis, Thought Technology Ltd., InteraXon Inc., Mind Media USA Inc., and NeuralScan.

*Definition: Neurotherapy, also called neurofeedback and electroencephalogram (EEG) biofeedback, is a drug-free treatment that helps people improve their brain function.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By System
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
    • Product Launches
    • Merger, Acquisition, Collaborations
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • Technology Landscape
    • PORTER’s Analysis
    • Pricing Analysis 
  4. Global Neurofeedback Market- Impact of Coronavirus (Covid-19) Pandemic
    •  Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Global Neurofeedback Market, By Product, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Amplifiers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Electrodes or Sensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Computer Software
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  6. Global Neurofeedback Market, By System , 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Frequency/Power Neurofeedback System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Slow Cortical Potential Neurofeedback (SCP-NF) System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Low-Energy Neurofeedback System (LENS)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Hemoencephalographic (HEG) Neurofeedback System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Live Z-Score Neurofeedback System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Low-Resolution Electromagnetic Tomography (LORE-TA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Functional Magnetic Resonance Imaging (fMRI)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  7. Global Neurofeedback Market, By Application, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segments Trends
    • Attention Deficit Hyperactivity Disorder (ADHD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Anxiety
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Epilepsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Insomnia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Drug Addiction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Schizophrenia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  8. Global Neurofeedback Market, By End User, 2017 – 2030, (US$ Million
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segments Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Ambulatory Surgical Center
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  9. Global Neurofeedback Market, By Region, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2030
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By System , 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Neuro Care Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Myndlift Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Brainmaster Technologies, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mitsar Co. Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Emotiv
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Brainworks
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mindfield Biosystems Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Narbis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thought Technology Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • InteraXon Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mind Media USA Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • NeuralScan
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  11. Section
    • Research Methodology
    • About Us

*Browse 35 market data tables and 30 figures on “Global Neurofeedback Market” - Global forecast to 2030

Detailed Segmentation:

  • Global Neurofeedback Market, By Product:
    • Amplifiers
    • Electrodes or Sensors
    • Computer Software
  • Global Neurofeedback Market, By System:
    • Frequency/Power Neurofeedback System
    • Slow Cortical Potential Neurofeedback (SCP-NF) System
    • Low-Energy Neurofeedback System (LENS)
    • Hemoencephalographic (HEG) Neurofeedback System
    • Live Z-Score Neurofeedback System
    • Low-Resolution Electromagnetic Tomography (LORE-TA)
    • Functional Magnetic Resonance Imaging (fMRI)
  • Global Neurofeedback Market By Application:
    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Anxiety
    • Depression
    • Epilepsy
    • Insomnia
    • Drug Addiction
    • Schizophrenia
    • Others
  • Global Neurofeedback Market By End User:
    • Hospitals
    • Ambulatory Surgical Center
    • Clinics
    • Others
  • Global Neurofeedback Market, By Region:
    • North America
      • By Product:
        • Amplifiers
        • Electrodes or Sensors
        • Computer Software
      • By System:
        • Frequency/Power Neurofeedback System
        • Slow Cortical Potential Neurofeedback (SCP-NF) System
        • Low-Energy Neurofeedback System (LENS)
        • Hemoencephalographic (HEG) Neurofeedback System
        • Live Z-Score Neurofeedback System
        • Low-Resolution Electromagnetic Tomography (LORE-TA)
        • Functional Magnetic Resonance Imaging (fMRI)
      • By Application:
        • Attention Deficit Hyperactivity Disorder (ADHD)
        • Anxiety
        • Depression
        • Epilepsy
        • Insomnia
        • Drug Addiction
        • Schizophrenia
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Center
        • Clinics
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product:
        • Amplifiers
        • Electrodes or Sensors
        • Computer Software
      • By System:
        • Frequency/Power Neurofeedback System
        • Slow Cortical Potential Neurofeedback (SCP-NF) System
        • Low-Energy Neurofeedback System (LENS)
        • Hemoencephalographic (HEG) Neurofeedback System
        • Live Z-Score Neurofeedback System
        • Low-Resolution Electromagnetic Tomography (LORE-TA)
        • Functional Magnetic Resonance Imaging (fMRI)
      • By Application:
        • Attention Deficit Hyperactivity Disorder (ADHD)
        • Anxiety
        • Depression
        • Epilepsy
        • Insomnia
        • Drug Addiction
        • Schizophrenia
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Center
        • Clinics
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product:
        • Amplifiers
        • Electrodes or Sensors
        • Computer Software
      • By System:
        • Frequency/Power Neurofeedback System
        • Slow Cortical Potential Neurofeedback (SCP-NF) System
        • Low-Energy Neurofeedback System (LENS)
        • Hemoencephalographic (HEG) Neurofeedback System
        • Live Z-Score Neurofeedback System
        • Low-Resolution Electromagnetic Tomography (LORE-TA)
        • Functional Magnetic Resonance Imaging (fMRI)
      • By Application:
        • Attention Deficit Hyperactivity Disorder (ADHD)
        • Anxiety
        • Depression
        • Epilepsy
        • Insomnia
        • Drug Addiction
        • Schizophrenia
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Center
        • Clinics
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product:
        • Amplifiers
        • Electrodes or Sensors
        • Computer Software
      • By System:
        • Frequency/Power Neurofeedback System
        • Slow Cortical Potential Neurofeedback (SCP-NF) System
        • Low-Energy Neurofeedback System (LENS)
        • Hemoencephalographic (HEG) Neurofeedback System
        • Live Z-Score Neurofeedback System
        • Low-Resolution Electromagnetic Tomography (LORE-TA)
        • Functional Magnetic Resonance Imaging (fMRI)
      • By Application:
        • Attention Deficit Hyperactivity Disorder (ADHD)
        • Anxiety
        • Depression
        • Epilepsy
        • Insomnia
        • Drug Addiction
        • Schizophrenia
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Center
        • Clinics
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product:
        • Amplifiers
        • Electrodes or Sensors
        • Computer Software
      • By System:
        • Frequency/Power Neurofeedback System
        • Slow Cortical Potential Neurofeedback (SCP-NF) System
        • Low-Energy Neurofeedback System (LENS)
        • Hemoencephalographic (HEG) Neurofeedback System
        • Live Z-Score Neurofeedback System
        • Low-Resolution Electromagnetic Tomography (LORE-TA)
        • Functional Magnetic Resonance Imaging (fMRI)
      • By Application:
        • Attention Deficit Hyperactivity Disorder (ADHD)
        • Anxiety
        • Depression
        • Epilepsy
        • Insomnia
        • Drug Addiction
        • Schizophrenia
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Center
        • Clinics
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global neurofeedback market during the forecast period (2023-2030)?

The global neurofeedback market is estimated to be valued at US$ 1,253.5 million in 2023 and is expected to exhibit a CAGR of 7.33% between 2023 and 2030.

What are the major factors driving the market growth

The increasing prevalence of mental disorders and increasing inorganic growth strategies such as collaborations are expected to drive the market.

Which is the leading product segment in the market?

Amplifiers is the leading product segment in the market. 

What are the key factors hampering growth of the market?

The major factors that can hamper the market include the side effects associated with the neurofeedback therapy.

Which are the major players operating in th market?

Major players operating in the market include Neuro Care Group, Myndlift Ltd, Brainmaster Technologies, Inc., Mitsar Co. Ltd, Emotiv, Brainworks, Mindfield Biosystems Ltd., Narbis, Thought Technology Ltd., InteraXon Inc., Mind Media USA Inc., and NeuralScan.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now